Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenetic Biosciences (XBIO) Accounts Payables (2023 - 2025)

Xenetic Biosciences (XBIO) has disclosed Accounts Payables for 5 consecutive years, with $578250.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Accounts Payables fell 24.52% year-over-year to $578250.0, compared with a TTM value of $578250.0 through Sep 2025, down 24.52%, and an annual FY2024 reading of $283615.0, down 50.13% over the prior year.
  • Accounts Payables was $578250.0 for Q3 2025 at Xenetic Biosciences, up from $346828.0 in the prior quarter.
  • Across five years, Accounts Payables topped out at $1.3 million in Q2 2024 and bottomed at $210483.0 in Q1 2024.
  • Average Accounts Payables over 3 years is $560496.4, with a median of $578250.0 recorded in 2025.
  • The sharpest move saw Accounts Payables surged 100.61% in 2024, then tumbled 73.4% in 2025.
  • Year by year, Accounts Payables stood at $568753.0 in 2023, then crashed by 50.13% to $283615.0 in 2024, then soared by 103.89% to $578250.0 in 2025.
  • Business Quant data shows Accounts Payables for XBIO at $578250.0 in Q3 2025, $346828.0 in Q2 2025, and $240293.0 in Q1 2025.